logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

EHA 2019 – Nelarabine in the real-world, an effective option for relapsed/refractory T-acute lymphoblastic leukaemia/lymphoma

In one of the largest cohorts of adult patients with the disease, nelarabine led to good response rates and was shown effective in bridging patients to transplant